Key OpinionTherapies for diabetic retinopathy: Latest news from the American Diabetes Association (dummy 1)
Key OpinionTherapies for diabetic retinopathy: Latest news from the American Diabetes Association (dummy 6)
Key OpinionGlycaemic control and weight reduction in type 2 diabetes with weekly tirzepatide, a novel GIP/GLP-1 agonist